| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Outlook for 2024
The Company's outlook for 2024 is unchanged, except to reflect the partial year impact of the acquisition of Englobe:
| 2024 Outlook | ||||||
| Measure | Actual 2023 | Prior | Englobe | Revised (with Englobe) | ||
| Revenue growth | -3% | +5% to +10% | +3% | +8% to +13% | ||
| Adjusted EBITDA growth | -6% | +5% to +15% | +3% | +8% to +18% | ||
| Adjusted EPS growth | -23% | +10% to +20% | +1% | +11% to +21% | ||
The financial outlook is based on the Company's best available information as of the date of this press release, and remains subject to change based on numerous macroeconomic, geopolitical, health, social and related factors. Continued interest rate volatility and/or lack of credit availability for commercial real estate transactions could materially impact the outlook.
Posted In: CIGI
